[
    {
        "id": "4709195",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-08-01T12:25:26-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) Q2 2024 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4709195-regeneron-pharmaceuticals-inc-regn-q2-2024-earnings-call-transcript"
        }
    },
    {
        "id": "4698613",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-06-11T10:07:05-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4698613-regeneron-pharmaceuticals-inc-regn-goldman-sachs-45th-annual-global-healthcare-conference"
        }
    },
    {
        "id": "4697590",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-06-05T12:43:09-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) Management presents at Jefferies 2024 Global Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4697590-regeneron-pharmaceuticals-inc-regn-management-presents-jefferies-2024-global-healthcare"
        }
    },
    {
        "id": "4693140",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-05-14T12:42:09-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals Inc (REGN) RBC Capital Markets Global Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4693140-regeneron-pharmaceuticals-inc-regn-rbc-capital-markets-global-healthcare-conference"
        }
    },
    {
        "id": "4688579",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-05-02T12:28:13-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) Q1 2024 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4688579-regeneron-pharmaceuticals-inc-regn-q1-2024-earnings-call-transcript"
        }
    },
    {
        "id": "4688439",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2024-05-02T08:29:58-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4688439-regeneron-pharmaceuticals-inc-2024-q1-results-earnings-call-presentation"
        }
    },
    {
        "id": "4677973",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-03-13T13:05:07-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) Leerink Partners Global Biopharma Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4677973-regeneron-pharmaceuticals-inc-regn-leerink-partners-global-biopharma-conference-transcript"
        }
    },
    {
        "id": "4677673",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-03-12T13:35:31-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) Barclays 26th Annual Global Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4677673-regeneron-pharmaceuticals-inc-regn-barclays-26th-annual-global-healthcare-conference"
        }
    },
    {
        "id": "4676418",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-03-06T15:33:05-05:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) TD Cowen 44th Annual Health Care Conference Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4676418-regeneron-pharmaceuticals-inc-regn-td-cowen-44th-annual-health-care-conference-call"
        }
    },
    {
        "id": "4670296",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-02-14T16:13:07-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) Oppenheimer 34th Annual Healthcare Life Sciences Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4670296-regeneron-pharmaceuticals-inc-regn-oppenheimer-34th-annual-healthcare-life-sciences"
        }
    },
    {
        "id": "4667116",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-02-02T11:59:04-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) Q4 2023 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4667116-regeneron-pharmaceuticals-inc-regn-q4-2023-earnings-call-transcript"
        }
    },
    {
        "id": "4667073",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2024-02-02T09:04:46-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4667073-regeneron-pharmaceuticals-inc-2023-q4-results-earnings-call-presentation"
        }
    },
    {
        "id": "4661804",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-01-08T20:25:04-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals Inc. (REGN) 42nd Annual JPMorgan Healthcare Conference - (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4661804-regeneron-pharmaceuticals-inc-regn-42nd-annual-jpmorgan-healthcare-conference-transcript"
        }
    },
    {
        "id": "4657940",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-12-14T13:56:03-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals Inc. (REGN) American Society of Hematology 2023 Investor Conference - (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4657940-regeneron-pharmaceuticals-inc-regn-american-society-of-hematology-2023-investor-conference"
        }
    },
    {
        "id": "4654605",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-11-28T11:15:26-05:00",
            "isLockedPro": false,
            "commentCount": 13,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) Piper Sandler 35th Annual Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4654605-regeneron-pharmaceuticals-inc-regn-piper-sandler-35th-annual-healthcare-conference-transcript"
        }
    },
    {
        "id": "4652099",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-11-15T12:38:02-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) Presents at Jefferies London Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4652099-regeneron-pharmaceuticals-inc-regn-presents-jefferies-london-healthcare-conference-transcript"
        }
    },
    {
        "id": "4650811",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-11-11T13:15:07-05:00",
            "isLockedPro": false,
            "commentCount": 2,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) Presents at Truist Securities BioPharma Symposium (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4650811-regeneron-pharmaceuticals-inc-regn-presents-truist-securities-biopharma-symposium-transcript"
        }
    },
    {
        "id": "4650803",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-11-11T12:49:07-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals Inc. (REGN) UBS Biopharma Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4650803-regeneron-pharmaceuticals-inc-regn-ubs-biopharma-conference-transcript"
        }
    },
    {
        "id": "4646599",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-11-02T13:14:09-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) Q3 2023 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4646599-regeneron-pharmaceuticals-inc-regn-q3-2023-earnings-call-transcript"
        }
    },
    {
        "id": "4646535",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2023-11-02T12:07:48-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4646535-regeneron-pharmaceuticals-inc-2023-q3-results-earnings-call-presentation"
        }
    },
    {
        "id": "4634385",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-09-11T12:53:07-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) Morgan Stanley 21st Annual Global Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4634385-regeneron-pharmaceuticals-inc-regn-morgan-stanley-21st-annual-global-healthcare-conference"
        }
    },
    {
        "id": "4633426",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-09-06T13:46:05-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at 2023 Wells Fargo Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4633426-regeneron-pharmaceuticals-inc-regn-management-presents-2023-wells-fargo-healthcare-conference"
        }
    },
    {
        "id": "4623329",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-08-03T12:23:03-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals Inc. (REGN) Q2 2023 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4623329-regeneron-pharmaceuticals-inc-regn-q2-2023-earnings-call-transcript"
        }
    },
    {
        "id": "4611528",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-06-14T14:39:07-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals Inc. (REGN) Presents at Goldman Sachs 44th Annual Global Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4611528-regeneron-pharmaceuticals-inc-regn-presents-goldman-sachs-44th-annual-global-healthcare"
        }
    },
    {
        "id": "4610054",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-06-07T12:43:08-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) Jefferies Global Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4610054-regeneron-pharmaceuticals-inc-regn-jefferies-global-healthcare-conference-transcript"
        }
    },
    {
        "id": "4608283",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-05-30T15:18:10-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) TD Cowen 4th Annual Oncology Innovation Summit (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4608283-regeneron-pharmaceuticals-inc-regn-td-cowen-4th-annual-oncology-innovation-summit-transcript"
        }
    },
    {
        "id": "4605131",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-05-16T13:57:03-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) 2023 RBC Capital Markets Global Healthcare Conference Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4605131-regeneron-pharmaceuticals-inc-regn-2023-rbc-capital-markets-global-healthcare-conference"
        }
    },
    {
        "id": "4604196",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-05-13T22:19:05-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) Bank of America Global Healthcare Conference Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4604196-regeneron-pharmaceuticals-inc-regn-bank-of-america-global-healthcare-conference-call"
        }
    },
    {
        "id": "4600062",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-05-04T14:24:09-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals Inc. (REGN) Q1 2023 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4600062-regeneron-pharmaceuticals-inc-regn-q1-2023-earnings-call-transcript"
        }
    },
    {
        "id": "4587616",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-03-15T11:39:06-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) Presents at Barclays Global Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4587616-regeneron-pharmaceuticals-inc-regn-presents-barclays-global-healthcare-conference-transcript"
        }
    },
    {
        "id": "4587066",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-03-13T14:49:10-04:00",
            "isLockedPro": false,
            "commentCount": 2,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) Oppenheimer 33rd Annual Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4587066-regeneron-pharmaceuticals-inc-regn-oppenheimer-33rd-annual-healthcare-conference-transcript"
        }
    },
    {
        "id": "4584990",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-03-06T16:23:07-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) Cowen 43rd Annual Health Care Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4584990-regeneron-pharmaceuticals-inc-regn-cowen-43rd-annual-health-care-conference-transcript"
        }
    },
    {
        "id": "4578280",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-02-14T15:42:07-05:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) SVB Securities Global Biopharma Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4578280-regeneron-pharmaceuticals-inc-regn-svb-securities-global-biopharma-conference-transcript"
        }
    },
    {
        "id": "4575144",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-02-03T12:43:06-05:00",
            "isLockedPro": false,
            "commentCount": 2,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) Q4 2022 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4575144-regeneron-pharmaceuticals-inc-regn-q4-2022-earnings-call-transcript"
        }
    },
    {
        "id": "4575142",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2023-02-03T12:42:09-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. 2022 Q4 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4575142-regeneron-pharmaceuticals-inc-2022-q4-results-earnings-call-presentation"
        }
    },
    {
        "id": "4568895",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-01-09T23:39:02-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) 41st Annual J.P. Morgan Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4568895-regeneron-pharmaceuticals-inc-regn-41st-annual-j-p-morgan-healthcare-conference-transcript"
        }
    },
    {
        "id": "4564966",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2022-12-16T13:31:35-05:00",
            "isLockedPro": false,
            "commentCount": 2,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals (REGN) Presents at 64th ASH Annual Meeting & Exposition",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4564966-regeneron-pharmaceuticals-regn-presents-64th-ash-annual-meeting-and-exposition"
        }
    },
    {
        "id": "4561481",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-11-30T13:53:06-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) Piper Sandler 34th Annual Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4561481-regeneron-pharmaceuticals-inc-regn-piper-sandler-34th-annual-healthcare-conference-transcript"
        }
    },
    {
        "id": "4561195",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-11-29T14:50:04-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) 5th Annual Evercore ISI HealthCONx Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4561195-regeneron-pharmaceuticals-inc-regn-5th-annual-evercore-isi-healthconx-conference-transcript"
        }
    },
    {
        "id": "4558457",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-11-16T12:24:19-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. (REGN) Jefferies London Healthcare Conference - (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4558457-regeneron-pharmaceuticals-inc-regn-jefferies-london-healthcare-conference-transcript"
        }
    },
    {
        "id": "1892851",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-12-11T15:51:07-05:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals' Management Presents at Oppenheimer & Co. Inc. 24th Annual Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1892851-regeneron-pharmaceuticals-management-presents-at-oppenheimer-and-co-inc-24th-annual-healthcare-conference-transcript"
        }
    },
    {
        "id": "1874331",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-12-03T14:04:03-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals Management Presents at Piper Jaffray Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1874331-regeneron-pharmaceuticals-management-presents-at-piper-jaffray-healthcare-conference-transcript"
        }
    },
    {
        "id": "1872551",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-12-02T18:16:07-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals' CEO Presents at Deutsche Bank 2013 BioFEST Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1872551-regeneron-pharmaceuticals-ceo-presents-at-deutsche-bank-2013-biofest-conference-transcript"
        }
    },
    {
        "id": "1807692",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-11-05T15:30:08-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1807692-regeneron-pharmaceuticals-management-discusses-q3-2013-results-earnings-call-transcript"
        }
    },
    {
        "id": "1682662",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-09-09T18:08:05-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals' Management Presents at Morgan Stanley Global Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1682662-regeneron-pharmaceuticals-management-presents-at-morgan-stanley-global-healthcare-conference-transcript"
        }
    },
    {
        "id": "1608542",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-08-06T13:30:06-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals Management Discusses Q2 2013 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1608542-regeneron-pharmaceuticals-management-discusses-q2-2013-results-earnings-call-transcript"
        }
    },
    {
        "id": "1606322",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-08-06T08:24:03-04:00",
            "isLockedPro": false,
            "commentCount": 2,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals Inc (REGN) Management Discusses Q2 2013 Results (Webcast)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1606322-regeneron-pharmaceuticals-inc-regn-management-discusses-q2-2013-results-webcast"
        }
    },
    {
        "id": "1494852",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-06-11T15:10:04-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals, Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-11-2013 08:40 AM",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1494852-regeneron-pharmaceuticals-inc-presents-at-goldman-sachs-34th-annual-global-healthcare-conference-junminus-11minus-2013-08-40-am"
        }
    },
    {
        "id": "1467621",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-05-29T13:20:26-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals' CEO Presents at 38th Annual Deutsche Bank Health Care Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1467621-regeneron-pharmaceuticals-ceo-presents-at-38th-annual-deutsche-bank-health-care-conference-transcript"
        }
    },
    {
        "id": "1447681",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-05-20T13:50:07-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals' Management Presents at UBS Global Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1447681-regeneron-pharmaceuticals-management-presents-at-ubs-global-healthcare-conference-transcript"
        }
    },
    {
        "id": "1399281",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-05-03T12:20:08-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1399281-regeneron-pharmaceuticals-management-discusses-q1-2013-results-earnings-call-transcript"
        }
    },
    {
        "id": "1268101",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-03-12T17:10:15-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals' CEO Presents at Barclays Global Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1268101-regeneron-pharmaceuticals-ceo-presents-at-barclays-global-healthcare-conference-transcript"
        }
    },
    {
        "id": "1227331",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-02-26T19:30:07-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals' Management Presents at Citi 2013 Global Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1227331-regeneron-pharmaceuticals-management-presents-at-citi-2013-global-healthcare-conference-transcript"
        }
    },
    {
        "id": "1184481",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-02-14T13:53:03-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals' CEO Discusses Q4 2012 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1184481-regeneron-pharmaceuticals-ceo-discusses-q4-2012-results-earnings-call-transcript"
        }
    },
    {
        "id": "1009071",
        "type": "transcript",
        "attributes": {
            "publishOn": "2012-11-14T21:39:01-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals' CEO Presents at Credit Suisse Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1009071-regeneron-pharmaceuticals-ceo-presents-at-credit-suisse-healthcare-conference-transcript"
        }
    },
    {
        "id": "946221",
        "type": "transcript",
        "attributes": {
            "publishOn": "2012-10-24T13:48:04-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals CEO Discusses Q3 2012 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/946221-regeneron-pharmaceuticals-ceo-discusses-q3-2012-results-earnings-call-transcript"
        }
    },
    {
        "id": "747551",
        "type": "transcript",
        "attributes": {
            "publishOn": "2012-07-25T12:28:04-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/747551-regeneron-pharmaceuticals-ceo-discusses-q2-2012-results-earnings-call-transcript"
        }
    },
    {
        "id": "538801",
        "type": "transcript",
        "attributes": {
            "publishOn": "2012-04-26T15:30:00-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals' CEO Discusses Q1 2012 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/538801-regeneron-pharmaceuticals-ceo-discusses-q1-2012-results-earnings-call-transcript"
        }
    },
    {
        "id": "361681",
        "type": "transcript",
        "attributes": {
            "publishOn": "2012-02-13T11:48:00-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/361681-regeneron-pharmaceuticals-ceo-discusses-q4-2011-results-earnings-call-transcript"
        }
    },
    {
        "id": "318446",
        "type": "transcript",
        "attributes": {
            "publishOn": "2012-01-09T22:48:15-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals' CEO Presents at the JPMorgan Global Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/318446-regeneron-pharmaceuticals-ceo-presents-at-the-jpmorgan-global-healthcare-conference-transcript"
        }
    },
    {
        "id": "311974",
        "type": "transcript",
        "attributes": {
            "publishOn": "2011-12-05T20:16:33-05:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals' CEO Presents at the 2011 Deutsche Bank BioFEST - Conference Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/311974-regeneron-pharmaceuticals-ceo-presents-at-the-2011-deutsche-bank-biofest-conference-call-transcript"
        }
    },
    {
        "id": "306735",
        "type": "transcript",
        "attributes": {
            "publishOn": "2011-11-09T16:16:56-05:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Regeneron Pharmaceuticals Management Hosts Credit Suisse Annual Healthcare Conference - Conference Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "2781",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/306735-regeneron-pharmaceuticals-management-hosts-credit-suisse-annual-healthcare-conference-conference-call-transcript"
        }
    }
]